Collaboration An Untapped Fuel For Driving Biopharma R&D

As biopharma R&D evolves with advanced modalities like CAR T and CRISPR, the complexity of therapeutics and the scarcity of specialized talent are creating new challenges. To stay ahead, researchers are increasingly turning to collaboration — not just within their organizations, but across industry, academia, and government. Explore how shared knowledge and pooled resources can accelerate innovation, fill capability gaps, and strengthen the global R&D ecosystem. Drawing on insights from over 1,200 pharma executives, this article highlights the disconnect between the desire to collaborate and the confidence in current systems. Examples of successful partnerships, from structured alliances to informal networking, show how collaboration can unlock new possibilities in drug development.

For those looking to advance cutting-edge therapies, the message is clear: working together isn’t just beneficial — it’s essential.